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ABSTRACT 
The Purpose of this review article is to discuss various critical paths for success of technology transfer. This article highlights the goal, methods, importance, 
facets and various models associated with technology transfer. A further detailed steps involved in technology transfer is described by understanding the 
problems associated during technology transfer. Licensing is one such phenomenon of technology transfer that has gained momentum in pharmaceutical 
industry where by pharmaceutical companies can contribute to research development. A major decision focuses on that point where the idea or process is 
advanced  from  a  research-oriented  program  targeted  toward  commercialization.  The  three  primary  considerations  to  be  addressed  during  an  effective 
technology transfer are the plan, the persons involved and the process. Few cases of technology transfer in pharmaceuticals. In conclusion to technology 
transfer is a complex issue and should be deal with using holistic approach. 
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INTRODUCTION  
Technology transfer is the process by which a developer of 
technology makes its technology available to a commercial 
partner  that  will  exploit  the  technology
1.  Pharmaceutical 
industry,  “technology  transfer”  refers  to  the  processes  of 
successful  progress  from  drug  discovery  to  product 
development,  clinical  trials  and  ultimately  full-scale 
commercialization
2.  There  are  two  types  of  technology 
transfer, vertical or horizontal. Vertical technology transfer 
refers  to  transfer  of  technology  from  basic  research  to 
development  and  production  respectively.  Whereas, 
horizontal  technology  transfer  refers  to  the  movement  and 
application  of  technology  used  in  one  place  or  context  to 
another place
3. The term technology transfer can be defined 
as the process of movement of technology from one unit to 
another. Commercial technology transfer may be defined as 
mutually agreed and goal-oriented. The transfer may be said 
to be successful if the receiving unit and the transferee can 
effectively  utilize  the  technology  for  business  gain.  The 
transfer involves cost and expenditure that should be agreed 
by the transferee and transferor. Technology transfer is both 
integral and  critical  to  drug  development  and  development 
process
4. The success  of any particular technology transfer 
depends upon process understanding or the ability to predict 
accurately the future performance of a process (Figure 1)
5. 
Technology  transfer  is  a  broad  set  of  processes  in  which 
technology is transferred between different stakeholder such 
as  governments,  private  sector,  nongovernmental 
organizations NGO’s and research institutions
6. 
Methods of technology transfer  
Licensing  is  the  most  common  method  of  technology 
transfer.  There  are  two  strategies  for  licensing  one  is 
licensing-in  and  licensing-out
7.  In  licensing-in  strategy, 
companies  that  are  small  and  lack  facilities  to  do  basic 
research and these facilities want to buy  other research. In 
case  of  licensing-out  strategy,  company’s  right  is  given to 
another party
8. 
Facets of technology transfer 
The transfer of technology could happen in any of following 
ways: 
1. Government labs to private sector firms. 
2. Between private sector firms of same country. 
3. Between private sector firms of different country. 
4. From academia to private sector firms. 
5. Academia, government and industry collaborations
9. 
Importance of technology transfer 
1.  Demonstration of necessary information to technology 
transfer  from  research  and  development  to  actual 
manufacturing. 
2.  Demonstration of necessary information to technology 
transfer  of  existing  product  between  various 
manufacturing places. 
3.  For  the  smooth  manufacturing  of  commercialized 
products
10. 
4.  General impact of the technology transfer program.   
i. Improvement of the research pertinence and its promotion 
in foreign countries.  
ii.  Contribution  with  the  creation  and  consolidation  of 
research  groups  and  centers  for  technology  development, 
involving the training of young research students.  
iii. Promote interdisciplinary projects to be developed in the 
region of interest
11.  
Reason of technology transfer 
Many reasons exist why a company would like to transfer its 
technology to other parties: 
1.  Due to lack of manufacturing capacity, the developer of 
the technology may only have manufacturing equipment 
that suitable for lab and small scale operations and must 
partner  with  another  organization  to  do  large  scale 
manufacturing.   
2.  Due to lack of resources to launch product commercially. 
The  original  inventor  of  technology  may  only  have 
resources to conduct early-stage research and Phase-I and 
II clinical trials.  
3.  Due  to  lack  of  marketing  distribution  and  distribution 
capability.  The  developer  of  the  technology  may  have 
fully developed the technology and even have obtained 
regulatory approvals and product registrations, but it may 
not  have  the  marketing  and  distribution  channels  and 
must  collaborate  with another  organization  that has  the 
capability
12. 
Effective factor in technology transfer 
In  the  technology  transfer  process,  the  entire  element  of 
technology  triangle  (Figure  2)  is  to  be  transferred  into 
organizations  and  not  impose  them  exclusively  into 
technology’s hardware parts. They should be fully aware of Shekhar Chander et al. IRJP 2012, 3 (6) 
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their  capabilities  and  requirements  before  launching 
technology  transfer.  Actually,  technological  evaluation, 
requirements  and  capacities  recognition  and  selection  of 
technology methods are of vital importance in the technology 
transfer process (Aghyi, 1999). Thus, awareness of effective 
factors  on  technology  transfer  is  of  great  importance  for 
technology recipients
13.  
Technology transfer problems commonly faced by Small 
and Medium Enterprises (SMEs)
 14 
Jagoda  and  Ramanathan(2007),  worked  on  the  problems 
faced by SMEs in planning and managing technology transfer 
may  be  classified  into  three  categories  are:  technology 
transfer  process  issues,  corporate  capability  issues  and 
operating  environment  and  network  information  system 
issues. The problems are summarized below: 
1. Problems during the technology justification and selection 
stage. 
i.  Wrong selection of technology based on misjudgment 
when  preparing  a  business  case  for  a  technology 
transfer project. 
ii.  Cost of buying, installing, operating and maintaining 
the technology is also high. 
iii.  The  technology  selected  is  also  complex  for  easy 
understanding and assimilation of the transferee. 
iv.  The  technology  needs  extensive  adaptation  to  suit 
local conditions. 
2. Problems during the planning stage. 
i.  Transferor  (seller)  underestimates  the  problems  in 
transferring  the  technology  to  a  developing  country 
setting. 
ii.  Transferor does not fully understand transferee needs. 
iii.  Transferee managers are not involved in the planning 
which is carried out only by the transferor. 
iv.  Too  much  attention  is  paid  to  the  hardware  to  be 
purchased  and not  enough attention is  paid to  skills 
and information acquisition. 
v.  Overestimation of the technological capabilities of the 
transferee  by  the  transferor  thereby  leading  to 
unrealistic expectations on how well the transferee can 
meet target dates. 
vi.  Poor market demand forecasting by the transferee of the 
outputs  to  be  produced  by  using  the  transferred 
technology. 
vii.  The objectives of the transferor and transferee are not 
compatible. 
viii.  Mechanisms chosen for implementing the transfer 
are not appropriate. 
3. Problems during negotiations. 
i.  Differences in negotiation approaches and strategies. 
ii.  Lack of trust between the transferor and transferee. 
iii.  Goal incompatibility during negotiations. 
iv.  Inability to reach agreements on pricing, product, and 
marketing strategies. 
v.  Both parties try to achieve results in an unrealistically 
short period of time.  
4. Problems during technology transfer implementation. 
i.  Shortage of experienced technology transfer managers. 
ii.  Lack  of  trust  in  transferor  developed  systems  by  the 
transferee. 
iii.  Inability to achieve quality targets. 
iv.  Delay  in  obtaining  supplementary  materials,  from  the 
local environment, needed for quick implementation. 
v.  High cost and poor quality of locally available materials 
needed to implement the technology transferred. 
vi.  Inadequate  tracking  of  the  technology  during 
implementation. 
vii.  Cost overrun due to poor implementation
15. 
Models of technology transfer 
The  difficulties  and  complexities  faced  by  managers  of 
technology  transfer  projects,  researchers,  consultants,  and 
practitioners  of  technology  transfer  have  been  proposing 
models  of  technology  transfer  that  could  facilitate  the 
effective planning and implementation of technology transfer 
projects.  Two  types  of  technology  transfer  models  are 
qualitative and quantitative. Qualitative models often have as 
their  objective  the  delineation  of  activities  involved  in 
managing  technology  transfer and the  elicitation  of  factors 
and issues that can influence the success and/or effectiveness 
of  technology  transfer.  Quantitative  models,  on  the  other 
hand,  aim  at  quantifying  parameters  of  significance  in 
technology transfer and analyzing them with a view towards 
minimizing goal incompatibility between the transferors and 
transferees of technology. 
Qualitative technology transfer models  
The  Bar-Zakay  model:  Bar-Zakay  (1971)  developed  a 
technology  transfer  model  based  on  a  project  management 
approach.  Technology  transfer  process  is  divided  into  the 
Search, Adaptation, Implementation and Maintenance stages. 
Bar-Zakay Model disadvantage limited relevance today since 
many of the activities, terms and ideas expressed reflected the 
setting  of  the  late  1960s  to  early  1970s,  when  buyers  of 
technology  were  mainly  passive  recipients  who  depended 
greatly on aid programs for the purchase of technology.  
The lessons that can be learnt from the Bar-Zakay model are 
the following: 
i.  There is a need for a comprehensive examination of the 
entire  technology  transfer  process  from  “search”  right 
through to “post-implementation” activities. 
ii.  The process approach must be adopted in planning and 
implementing technology transfer projects. 
iii.  Milestones  and  decision  points  are  important  so  that 
activities can be strengthened, mistakes corrected, or even 
the project terminated at any point in time
16. 
The  Behrman  and  Wallender  model:  Behrman  and 
Wallender (1976) have proposed a seven stage process for 
international technology transfer that may be more relevant to 
multinational corporations. The seven stages are: 
i.  Manufacturing  proposal  and  planning  to  arrive  at 
decisions  regarding  location and  preparing  a  business 
case including good resource assessments. 
ii.  Deciding  the  product  design  technologies  to  be 
transferred. 
iii.  Specifying details of the plant to be designed to produce 
the product and other aspects related to construction and 
infrastructure development. 
iv.  Plant construction and production start-up. 
v.  Adapting  the  process  and  product  if  needed  and 
strengthening  production  systems  to  suit  local 
conditions. 
vi.  Improving  the  product  technology  transferred  using 
local skills. 
vii.  Providing external support to strengthen the relationship 
between the transferor and transferee. 
The weakness of this model is that, during the first three 
stages  the  transferor  develops  the  technology  transfer 
project  with  minimal  involvement  of  the  transferee 
thereby reinforcing dependency
17. Shekhar Chander et al. IRJP 2012, 3 (6) 
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The  Dahlman  and  Westphal  model:  Dahlman  and 
Westphal (1981) model have proposed a nine stage process 
model as follows: 
i.  Pre-investment  feasibility  is  carried  out  to  gather 
information  and  establishing  project  viability  that  are 
carried out for techno-economic. 
ii.  On the basis of feasibility study there is a need to carry 
out a preliminary identification of technologies. 
iii.  Carry  out  basic  engineering  studies  that  involve  the 
preparation of process flow diagrams, layouts, material 
and energy balances and other design specifications of 
the plant and machinery and the core technology to be 
transferred. 
iv.  To  make  the  transfer  effective  carry  out  a  detailed 
engineering  study  that  involve  the  preparation  of  a 
detailed civil  engineering plan for the facility, including 
construction  and  installation  specifications  and 
identification of the peripheral technology needed. 
v.  The  subcontracting  services  are  carried  out  for    the 
selection of suppliers to assemble the plant machinery, 
equipment and plan for the co-ordination of the work 
among various parties. 
vi.  The  education  plan  and  training  are  executed  in 
consultation  with  the  suppliers  of  technology  for  the 
workers  who  would  be  employed  in  the  technology 
transfer project. 
vii.  The plant is constructed. 
viii.  Operations are commenced. 
ix.  Develop  trouble-shooting  skills  and  put  in  place 
arrangements to solve design and operational problems 
as  they  arise,  especially  during  the  early  years  of 
operation. 
x.  Its major weakness is that it assumes that the transferee 
will have access to high-level engineering skills
18. 
The Schlie, Radnor and Wad model: Schlie et al. (1987) 
propose  a  simple,  generic  model  that  delineates  seven 
elements that can influence the planning, implementation and 
eventual  success  of  any  technology  transfer  project.  These 
seven elements are listed below. 
i.  The transferor, which is the unit selling the technology 
to the recipient. 
ii.  The transferee, which is the unit buying the technology. 
iii.  The technology that is being transferred. 
iv.  The transfer mechanism that has been chosen to transfer 
the chosen technology. 
v.  The  transferor  environment  is  the  immediate  set  of 
conditions,  in  which  the  transferor  is  operating. 
Attributes  of  the  transferor  environment  that  can 
influence  the  effectiveness  of  the  transfer  process 
include,  among  others,  economic  status,  business 
orientation  (inward  versus  outward),  stability,  attitude 
and commitment to the transfer project, and operating 
policies. 
vi.  The  transferee  environment  is  the  immediate  set  of 
conditions  under  which  the  transferee  is  operating. 
Attributes  of  the  transferee  environment  that  can 
influence  the  absorptive  capacity  of  the  transferee 
include physical and organizational infrastructure, skills 
availability,  attitude  and  commitment  to  the  transfer 
project,  technological  status,  business  orientation 
(inward versus outward), economic status  and stability. 
vii.  The greater environment which is surrounding both the 
transferor and the transferee. There may be layers of this 
environment that are sub-regional, regional and global. 
Even  if  the  immediate  operating  environments  of  the 
transferor  and  the  transferee  are  favorable  to  the 
technology  transfer,  if  the  layers  of  the  greater 
environment are not supportive, then cross-border and 
international  technology  transfer  could  be  adversely 
affected.  Factors  in  the  greater  environment  such  as 
political  relationships  between  countries,  exchange 
rates, investment climates, trade negotiations, balance of 
trade,  relative  technological  levels,  and  the  status  of 
intellectual  property  protection  regimes  could  have  a 
great influence on the success of a technology transfer 
project
19. 
Lee et al. (1988) have developed a longitudinal model of 
technology transfer based on a study of developing and 
rapidly industrializing countries. The need of transferee 
firm to put in place strategies to be able to go through the 
stages  of  acquisition,  assimilation,  and  eventual 
improvement
20. 
The  Chantramonklasri  model:  Chantramonklasri  (1990) 
who proposes a five phase model as shown in (Figure 3). The 
five phases of this model are as follows: 
i.  Carrying out a pre-investment and feasibility study 
ii.  On the basis of feasibility study developing engineering 
specifications and design.  
iii.  Commence  capital  goods  production  based  on  the 
engineering  specifications  and  designs that have  been 
developed. 
iv.  Commissioning and start-u including comprehensive of 
the workforce. 
v.  Commercial production
 commences
21. 
UNIDO  (1996)  model,  in  which  endorsement  of  the  Bar-
Zakay approach, suggests that in the manufacturing sector, 
once the need for a technology transfer project is established 
the  steps  of  search,  evaluation,  negotiation,  contract 
execution,  technology  adaptation and  absorption  should  be 
followed sequentially to ensure effectiveness
22. 
Durrani  et  al.  (1998)  have  proposed  a  generic  model 
consisting of five steps: 
i.  Market-place requirements to be established. 
ii.  Identifying technology solutions. 
iii.  Classifying the identified technology solutions. 
iv.  Establishing sources from where the desired technology 
could be acquired. 
v.  Technology-acquisition decision was finalized
23. 
Quantitative technology transfer Models 
Sharif  and  Haq  (1980)  proposed  the  concept  of  Potential 
Technological  Distance  (PTD)  between  a  transferor  and 
transferee and argues that when the PTD is either too great or 
too  small  between  the  transferor  and  transferee,  the 
effectiveness of the transfer is low. It suggests that when a 
transferee first looks for a potential transferor it is important 
to look for one with an “optimal” PTD
24. 
Raz  et  al  (1983) have  presented  a model  of  technological 
“catch-up”  that  shows  how  a  technology  leader,  through 
technology  transfer,  can  assist  the  rate  of  technological 
development of a technology follower. The model examines 
three phases of growth of a technology follower namely, the 
slow initial phase with high technological capability gap, the 
faster learning phase with the decreasing gap, and catch-up 
phase when the technological gap is very small or closed
25. 
Klein  and  Lim  (1997)  have  studied  the  technology  gap 
between the general machinery and electrical and electronic 
industries  of  Korea  and  Japan.  This  model  suggests  that 
technology transfer from leaders can play a critical role in 
upgrading the technological levels  of  follower firms. Their 
study also shows that the followers should supplement the Shekhar Chander et al. IRJP 2012, 3 (6) 
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transfer  by  independently  putting  in  place  measures  to 
assimilate,  modify,  and  localize  the  technology  transferred 
from the leader
26. 
Steps in technology transfer 
During the development of a formulation, it is important to 
understand  the  procedure  of  operations    used,  critical  and 
non-critical  parameters  of  each  operation,  production 
environment, equipment and excipients availability should be 
taken into account during the early phases of development of 
formulation so that successful scale up can be carried out. 
The steps involved in technology transfer are as follows – 
Development of technology by research and development. 
(Research Phase) 
i.  Design  of  procedure  and  selection  of  excipients  by 
research and development: Selection of   materials 
and design of procedures is developed by research and 
development  on  the  basis  of  innovator  product 
characteristics. 
ii.  Identification  of  specifications  and  quality  by 
research and development: Quality of product should 
meet the specifications of an innovator product. 
Technology  transfer from  research  and  development  to 
production  (Development  Phase):  Research  and 
development  provides  Technology  Transfer  Dossier  (TTD) 
document to product development laboratory which contains 
all information of formulation and drug product as follows - 
i.  Master  Formula  Card  (MFC):  Master  formula  card 
contains product name along with its strength, generic 
name, MFC number, page number, effective date, shelf 
life and market. 
ii.  Master  Packing  Card:  Master  packing  card  gives 
information  about  packaging  type,  material  used  for 
packaging, stability profile and shelf life of packaging. 
iii.  Master  Formula:  Master  formula  gives  information 
about formulation order and manufacturing instructions. 
(Process order and environment conditions) 
iv.  Specifications  and  Standard  Test  Procedures 
(STP’S):  Specifications  and  standard  test  procedures 
are  helps  to  know  active  ingredients  and  excipients 
profile,  in-process  parameters,  product  release 
specifications and finished product details. 
Optimization and Production. (Production Phase) 
i.  Validation  studies:  Validation  studies  verify  that 
process  is  stabilize  the  product  based  on  transferred 
manufacturing formula and Production is implemented 
after  validation  studies.  Manufacturing  department  is 
accepting  technology  and  responsible  for  validation. 
The research and development department transferring 
technology  should  take  responsibility  for  validation 
such as performance qualification, cleaning and process 
validation. 
ii.  Scale up for production: Scale up involves the transfer 
of  technology  during  small  scale  development  of  the 
product  and  processes.  It  is  essential  to  consider  the 
production environment and system during development 
of  process.  Operators  should  concentrate  on  keeping 
these things in mind that their segment of the production 
process  running  smoothly  if  technology  transfer  is 
implemented thoughtfully. Effective technology transfer 
helps  to  provide  process  efficiency  and  maintain 
product quality. 
Technology transfer documentation: Technology transfer 
document demonstrating the contents of technology transfer 
from transferring and transferred parties. Every step from 
research  and  development  to  production  should  be 
documented,  task  assignments and responsibilities  should 
be  clarified  and  acceptance  criteria  for  completion  of 
technology transfer concerning individual technology to be 
transferred. It is duty of Quality Assurance department to 
check and approve the documentation for all processes of 
technology transfer. 
i.  Development  report:  The  research  and  development 
report is a file of technical development, research and 
development  department  is  in-charge  of  its 
documentation. This report is an important file to show 
basis for the quality design of drug substances and its 
specifications and test methods. The development report 
is not prerequisite for the application for approval it can 
be  used  at  the  pre  approval  an  inspection  as  valid 
document  for  quality  design  of  new  drug.  The 
development  report  contains  -  (a)  Data  of 
pharmaceutical  development  of  new  drug  substances 
and  drug  products  at  stages  from  early  development 
phase to final application of approval. (b) Information 
of  raw  materials  and  components.  (c)  Design  of 
manufacturing  methods.  (d)  Change  in  histories  of 
important  processes  and  control  parameters.  (e) 
Specifications and test methods of drug substances. (f) 
Validity of specification range of important tests such as 
contents impurities and dissolution. (g) Verifications of 
results. 
ii.  Technology  transfer  plan:  The  technology  transfer 
plan  describe  items  and  contents  of  technology  to  be 
transferred  and  detailed  procedures  of  individual 
transfer  and  transfer  schedule,  establish  judgment 
criteria  for  the  completion  of  the  transfer.  The 
transferring  party  should  prepare  the  plan  before  the 
implementation of the transfer and reach an agreement 
on its contents with the transferred party. 
iii.  Report: The Completion of technology transfer is to be 
made once data are taken accordingly to the technology 
plan and are evaluated to confirm that the predetermined 
judgment  criteria  are  met.  Both  transferring  and 
transferred  parties  should  document  the  technology 
transfer report. 
iv.  Exhibit: After taking scale up batches of the product, 
manufacturing of exhibit batches takes place. In case of 
exhibit, batch sizes are increased along with equipments 
and their processes. This is done for filling purpose in 
regulatory agencies
27. 
Few cases of technology transfer 
In  India  technology  transfer  process  is  actively  pursued 
through government laboratories,  academic  institutions  and 
commercial  entities  such  as  companies.  Government 
laboratories and institution are the frontrunner in creating and 
transferring  the  technology.  The  pharmaceutical  company 
likes  Cipla  has  technology  transfer  agreement  with 
companies  in  Uganda,  Nigeria,  Egypt,  Algeria.  Themis 
laboratory has entered in technology transfer agreement with 
Aventis  Pharma  Ltd  for  the  development  of  fixed  dose 
combination  of  glibenaclamide  and  glimepride  with 
metfomin  technology  patented  by  Themis
28.  Eli  Lilly  has 
entered  in  technology  transfer  agreement  with  Shasun 
Chemical and Drugs for the manufacturing of anti-TB drug, 
Cycloserine  produced  by  Shasun  to  meet  Eli  Lilly  global 
demand
29.  Local  subsidiaries  of  foreign  R&D-based 
pharmaceuticals  such  as  Pfizer,  Abbott,  GlaxoSmithKline 
Beecham,  Bayer,  Boehringer  Ingelheim,  Aventis,  Novartis, 
Merck,  Sharp  &  Dohme,  AstraZeneca,  Schering  Plough, 
Wyeth  and  Bristol-Myers  Squibb  bought  local  factories  to Shekhar Chander et al. IRJP 2012, 3 (6) 
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establish their operations, although it appears that some of 
these  factories  have  been  bought  back  by  local  firms. 
Laboratorio  Elea  (ELEA)  also  possesses  licences  to 
commercialize  products  made  by  Chiron  Corporation 
(vaccines)  and  Novo  Nordisk  (hormone  therapy)  and  a 
promotion agreement with Novartis for its line of transdermal 
patches in hormone therapy
30. In 1999, the current provider 
of  Velcade  Millennium  Pharmaceuticals,  collaborated  with 
DanaFarber  cancer  institute  to  study  Velcade  in  multiple 
myeloma  patients  after  the  University  of  North  Carolina  
achieved a complete response with the compound in the  first 
multiple  myeloma  patient
31.  Indian  pharmaceutical 
companies  like  Wockhardt  ltd,  Cipla  ltd,  Torrent 
pharmaceutical ltd, Dr Reddy’s laboratories ltd, USV ltd have 
already  signed  in-licensing  agreements  with  foreign  drug 
markers.  Ranbaxy  is  looking  for  in-licensing  opportunities 
for novel drug delivery system
32. 
CONCLUSION 
A  dedicated  technology  transfer  organization  is  set  up  to 
facilitate and execute the process. Technology transfer can be 
considered  successful  if  a  receiving  unit  can  routinely 
reproduce the transferred product, process or method against 
a predefined set of specifications is agreed with a sending 
unit  and/or  a  development  unit.  Licensing  is  an  important 
phenomenon  of  technology  transfer  that  has  gained 
momentum  in  pharmaceutical  industry  by  which 
pharmaceutical  companies  can  contribute  to  research  and 
development.  The  three  primary  considerations  to  be 
addressed  during  an  effective  technology  transfer  are  the 
plan, the persons involved and the process. The research and 
development  centers  should  have  their  own  model  for  the 
management  and  innovation  to  make  them  more  versatile 
evaluating  technical  and  commercial  possibilities  for  new 
process  or new services. Technology transfer is a complex 
issue and should be deal with using holistic approach. 
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Figure 1. Process Development Work Flow in Pharmaceutical Industry. 
Source (Yaswanth Allamneni). 
 
 
 
Figure 2. Technology Transfer Process. Source (Aghyi, 1999) 
 
 
Figure 3 Five –Phase Model of International Technology Transfer. 
Source (Chantramonklasri 1990). 
   
 
 
 
  